Again, on July 16, 1999, RIL just crawled past Rs 200 but closed substantially lower at Rs 185.70.

``It was important for the counter to close above Rs 200 by a convincing margin. The counter still offers a decent rise from current levels of Rs 210,'' said a fund manager. Rumours about the commissioning of first line of RIL's paraxylene aided the sentiment. ``The rumour that RIL is going for NYSE listing soon has gathered momentum. The company has reportedly completed its GAAP requirements and the company is likely to go for NYSE listing between 10-15 October,'' said a broker.

Zee Telefilms

The Zee stock continued its unbridled run on the bourses and closed 2.87 per cent up at Rs 4738 on the NSE. The news of News Corp acquiring 7.5 per cent stake in the company came after market hours and at Calcutta kerb, the stock flared up to Rs 5000. According to market sources, News Corp is likely to pay Rs 5500 per share for its acquisition in Zee. ``The deal will result in lot of value addition in the company. Zee is also planning to strengthen its regional presence by launching two channels by end of this year,'' said a fund manager.

Raymond Synthetics

The Reliance tag also unleashed bulls on Raymond Synthetics. Sources point out that Reliance finally bought Raymond Synthetics at Rs 8-9 per share. Raymond Synthetic scrip hit the circuit on the BSE at Rs 10.95 and remained frozen for the rest of the day. The counter saw a huge volume of 4.13 lakh shares, one of the highest in the counter's history.

Nicholas Piramal

The scrip touched a high of Rs 506 before closing at Rs 486 on the BSE. The scrip has seen a steady rise from a low of Rs 428 on September 17. The counter saw a huge volume of 1.4 lakh shares. The fervour is attributed to the company's new anti-cancer drug for which it is in advanced trials in association with a US firm.